{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:13:05Z","timestamp":1790485985533,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2623,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/ki.2008.252","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T12:49:29Z","timestamp":1213793369000},"page":"910-918","source":"Crossref","is-referenced-by-count":44,"title":["Rosiglitazone reverses tenofovir-induced nephrotoxicity"],"prefix":"10.1016","volume":"74","author":[{"given":"Alexandre B.","family":"Lib\u00f3rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo V.B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita R.C.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H.","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Seguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.252_bb0010","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0149-2918(02)80058-3","article-title":"Tenofovir disoproxil fumarate","volume":"24","author":"Fung","year":"2002","journal-title":"Clin Ther"},{"key":"10.1038\/ki.2008.252_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","article-title":"Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics","volume":"43","author":"Kearney","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1038\/ki.2008.252_bb0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/ki.2008.252_bb0025","series-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Clinical Practices for Treatment of HIV Infection","year":"2006"},{"key":"10.1038\/ki.2008.252_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.252_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/00365540310016169","article-title":"Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1","volume":"36","author":"Breton","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1038\/ki.2008.252_bb0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2008.252_bb0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jinf.2005.07.020","article-title":"Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?","volume":"52","author":"Badiou","year":"2006","journal-title":"J Infect"},{"key":"10.1038\/ki.2008.252_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1468-1293.2005.00308.x","article-title":"Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study","volume":"6","author":"Antoniou","year":"2005","journal-title":"HIV Med"},{"key":"10.1038\/ki.2008.252_bb0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.aids.0000216386.60481.47","article-title":"Serum creatinine changes in HIV-seropositive patients receiving tenofovir","volume":"20","author":"El Sahly","year":"2006","journal-title":"AIDS"},{"key":"10.1038\/ki.2008.252_bb0060","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1359\/jbmr.2004.19.5.714","article-title":"Fanconi's syndrome in HIV+ adults: report of three cases and literature review","volume":"19","author":"Earle","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2008.252_bb0065","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00002030-200404300-00019","article-title":"Renal safety of tenofovir in HIV treatment-experienced patients","volume":"18","author":"Izzedine","year":"2004","journal-title":"AIDS"},{"key":"10.1038\/ki.2008.252_bb0070","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.252_bb0075","doi-asserted-by":"crossref","first-page":"E174","DOI":"10.1086\/379829","article-title":"Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir\u2013ritonavir\u2013didanosine","volume":"37","author":"Rollot","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2008.252_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1468-1293.2005.00318.x","article-title":"The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy","volume":"6","author":"Parsonage","year":"2005","journal-title":"HIV Med"},{"key":"10.1038\/ki.2008.252_bb0085","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AAC.48.5.1469-1487.2004","article-title":"Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy) propyl]adenine (tenofovir) to newborn and infant rhesus macaques","volume":"48","author":"Van Rompay","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/ki.2008.252_bb0090","first-page":"590","article-title":"Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions","volume":"6","author":"Michalik","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"10.1038\/ki.2008.252_bb0095","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/ndt\/gfl448","article-title":"Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?","volume":"21","author":"Boulanger","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.252_bb0100","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1097\/01.ASN.0000139067.83419.46","article-title":"Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome","volume":"15","author":"Guan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.252_bb0105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/jpet.103.058008","article-title":"Rosiglitazone activates renal sodium and water-reabsorptive pathways and lowers blood pressure in normal rats","volume":"308","author":"Song","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/ki.2008.252_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1523-1755.2004.00359.x","article-title":"Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia","volume":"65","author":"Andrade","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.252_bb0115","doi-asserted-by":"crossref","first-page":"F925","DOI":"10.1152\/ajprenal.2000.278.6.F925","article-title":"Decreased abundance of major Na+ transporters in kidneys of rats with ischemia-induced acute renal failure","volume":"278","author":"Kwon","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2008.252_bb0120","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/ki.2008.252_bb0125","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00002030-200501030-00012","article-title":"Antiretroviral therapy with tenofovir is associated with mild renal dysfunction","volume":"19","author":"Mauss","year":"2005","journal-title":"AIDS"},{"key":"10.1038\/ki.2008.252_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"10.1038\/ki.2008.252_bb0135","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfh658","article-title":"Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients: data from a double-blind randomized active-controlled multicentre study","volume":"20","author":"Izzedine","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.252_bb0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.252_bb0145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1590\/S0100-879X2006000800009","article-title":"Urinary NO3 excretion and renal failure in indinavir-treated patients","volume":"39","author":"Eira","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1038\/ki.2008.252_bb0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/135965350300800405","article-title":"Vasodilator agents protect against indinavir nephrotoxicity","volume":"8","author":"de Ara\u00fajo","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1038\/ki.2008.252_bb0155","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.2001.0590051899.x","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonist troglitazone protects against nondiabetic glomerulosclerosis in rats","volume":"59","author":"Ma","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.252_bb0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000072088","article-title":"Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia\/reperfusion injury","volume":"23","author":"Sivarajah","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2008.252_bb0165","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/ndt\/gfl194","article-title":"Rosiglitazone ameliorates cisplatin-induced renal injury in mice","volume":"21","author":"Lee","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.252_bb0170","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.ATV.0000177805.65864.d4","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor \u03b3-dependent mechanisms","volume":"25","author":"Polikandriotis","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2008.252_bb0175","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/01.aids.0000194130.05264.83","article-title":"Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels","volume":"19","author":"Kinae","year":"2005","journal-title":"AIDS"},{"key":"10.1038\/ki.2008.252_bb0180","first-page":"F133","article-title":"Upregulation of Na+ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats","volume":"284","author":"Na","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2008.252_bb0185","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/01.aids.0000238416.05819.09","article-title":"Hypokalemia in HIV patients on tenofovir","volume":"209","author":"Cirino","year":"2006","journal-title":"AIDS"},{"key":"10.1038\/ki.2008.252_bb0190","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.00251-06","article-title":"Mechanism of active renal tubular efflux of tenofovir","volume":"50","author":"Ray","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/ki.2008.252_bb0195","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0090-9556(24)15347-0","article-title":"Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans","volume":"28","author":"Cox","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/ki.2008.252_bb0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPAR\u03b3 stimulation of ENaC-mediated renal salt absorption","volume":"11","author":"Guan","year":"2005","journal-title":"Nat Med"},{"key":"10.1038\/ki.2008.252_bb0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1152\/ajprenal.00335.2004","article-title":"Regulation of the renal thiazide-sensitive Na\u2013Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone","volume":"289","author":"Khan","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2008.252_bb0210","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.252_bb0215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP.9.5.406","article-title":"Thiazolidinediones, peripheral edema and type 2 diabetes: incidence, pathophysiology, and clinical implications","volume":"9","author":"Mudaliar","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1038\/ki.2008.252_bb0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-3542(03)00005-6","article-title":"Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks","volume":"58","author":"Biesecker","year":"2003","journal-title":"Antiviral Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381553425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381553425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:45:07Z","timestamp":1738262707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381553425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S008525381553425X"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.252","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}